Navigation Links
Reportlinker Adds Global Biochips Industry
Date:3/21/2011

NEW YORK, March 21, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Biochips Industry

http://www.reportlinker.com/p098235/Global-Biochips-Industry.html

This report analyzes the worldwide markets for Biochips in US$ Million by the following product segments - DNA Chips, Protein Chips, and Lab Chips. Annual estimates and forecasts are provided for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Middle East, and Latin America. The report profiles 77 companies including many key and niche players such as Affymetrix, Agilent Technologies, Biomerieux, Bio-Rad Laboratories, Inc., Caliper Life Sciences, Cepheid Inc., GE Healthcare Ltd., Life Technologies Corporation, Ocimum Biosolutions Ltd., Takara Bio, Inc., Clontech Laboratories, Inc., and Zyomyx. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Data Interpretation & Reporting Level 3

Quantitative Techniques & Analytics 3

Product Definitions and Scope of Study 3

A. DNA Chips 3

B. Protein Chips 4

C. Lab Chips 4

2. INDUSTRY OVERVIEW 5

A Primer 5

Recession Dries Up Funds for Biotech Firms 5

Promising Biochips Promote Biological Research 6

Current and Future Analysis 7

Key Forces Driving the Industry 7

DNA Chips Lead the Application Front 7

Protein Biochips - Set for Robust Expansion 8

Lab-on-a-Chips: Fusion of Nanotechnology & Genetic Engineering 8

Industry Challenges 9

Standardization: A Key Challenge 9

Price Dearness Pauses Biochips Growth 9

3. MARKET DYNAMICS 10

Current Approaches to Biochips 10

The Business of Biochips 10

Technological Differentiation in Demand 11

Focus on Highly Intelligent Diagnostic Systems 11

Scalability & Pricing - Focus Areas 11

Biochips: Expanding Role in Diagnostic Medicine 12

Advancements in Biochip Technology 12

Biochip Technology Boosts Personalised Medicine 13

Biochip Technology Spreads beyond Pharma Industry 13

Proteomics "Chip" into Biochip Technology 14

Towards Increasing Minaturization 14

Technological Trends 14

Sensitivity 14

Microfabrication 14

Density 15

Integrated Chips 15

Patent Trends 15

Table 1: Number of Lab-on-a-Chip Patents (includes

corresponding Graph/Chart) 15

Table 2: % of Lab-on-a-Chip Patent Documents by

Country/Authority of Origin (January 2008 - April 2009)

(includes corresponding Graph/Chart) 16

Table 3: Number of Lab-on-a-Chip Documents by Patent

Assignees (January 2008 - April 2009) (includes

corresponding Graph/Chart) 16

Patent Applications 17

4. COMPETITION 18

Industry Structure 18

Major Participants 18

Affymetrix: A Major Market Player 18

Other Market Players 19

Growing Partnerships between Pharma and Biotech Companies 19

Tech Giants Join the Biochip Fray 20

5. PRODUCT OVERVIEW 21

Biochips - Complex Blend of Biochemistry and Electronics 21

Historical Perspective 21

Lab-on-a-chip: An Enabled Technology 23

Utility 23

Evolution and Segmentation 23

Differing Perspectives 23

Classification of Biochips 24

Need for Biochips 25

Manufacturing Systems Used in Biochip Manufacture 25

Working of a Biochip 26

DNA Transcription & Translation Through A Biochip 26

A Functional Model 26

Cocktail of Disparate Technically Specialized Applications 27

Biochips: By-product of Multi-disciplinary Sciences 27

Nanotechnology 27

BioMEMS 27

Microfluidics 28

Micro Total Analysis System 28

6. BIOCHIP AND MICROARRAY CONSTRUCTION 30

Chip Architecture 30

Essence of a Biochip 30

Concept of a Microarray 30

Microarray Modules 30

High Degree of Automation Spurs Biochips Use 31

Microfabrication Technology in Biochips made from Polymer and

Plastics 31

Micro-optics in Biochips 32

Liquid Handling Through Micro-Dispensers 32

Capillary Electrophoresis and Electrochemical Detectors 32

Other Technologies 32

Management of Bio-information 32

Scanning 33

Microarray Database Management 33

Classification of DNA Chips 33

General Description of Spotted cDNA Microarrays 33

Spotted DNA Arrays 34

Spotted cDNA Versus Spotted Oligonucleotide Arrays 34

Limitations of Conventional cDNA Microarrays 34

Protein Biochips 35

General Applications of Protein Biochips 35

Challenges in the Design of a Protein Biochip 36

Limitations of Protein Chip Technology 36

Concluding Remarks for Protein Biochips 37

7. APPLICATIONS OF BIOCHIPS 38

Biochip Uses 39

Pharmaceutical Investigation 39

Medical Diagnostics 39

Advantages of Biosensor Chip Technology 40

Forensics 40

Transplantation Screening 40

Identity Testing 40

Water and Environmental Testing 41

Food Industry 41

8. PRODUCT INNOVATIONS AND DEVELOPMENTS 42

Randox Launches Evidence Evolution Analyzer 42

South Korea Develops Instant Microfluidic Biochip 42

Fluidigm Introduces Reusable FR48.48 Dynamic Array™ IFC 42

Cellix Introduces Vena4Y™ and Vena4Y2™ Biochips 42

Agilent Technologies Unveils Workflow HPLC-Chip 43

Febit Holding Introduces First Human Cancer Biochip 43

Blue4Green Rolls Out Lab-on-a-chip Solution 44

Randox Laboratories Unveils Biochip Arrays 44

Randox Laboratories Introduces Evidence Investigator 44

Randox Unveils Innovative DoA Biochips for Rapid Drug Screening 45

Randox Launches Revolutionary Biochip Analyser for Multiple

Cardiac Testing 45

Febit Unveils Biochip for DNA/RNA Detection and Enrichment on

Mouse Genome 46

Veredus Laboratories Launches Portable Test Kit for H1N1 Flu 46

Randox Develops Multi Marker Cardiac Biochip Array for MI

Diagnosis 46

VigeneTech and CapitalBio Launch Completely Integrated

Microarray Solution Platform 47

9. PRODUCT INNOVATIONS/DEVELOPMENTS IN THE RECENT PAST - A

PERSPECTIVE BUILDER 48

Randox Introduces New Biochip Array for CAMs Testing 48

Cellix Announces Global Launch of VenaEC Biochip 48

Decision Biomarkers Rolls Out AVANTRA™ Biomarker Workstation

System 48

Osaka Develops Biocompatible Monomers for Biochips 49

Iris BioTechnologies Launches New Nano-Biochip 49

Affymetrix Introduces Complete Cytogenetic Solution 49

Agilent Unveils 244K CGH Micro-Array 50

Randox Unveils World's First Protein Biochip 50

Randox Introduces Thyroid Array Biochip 50

Sigma Launches ChIP Kit 51

Randox Develops Biochip for Synthetic Steroids 51

US and Czech Scientists to Develop Biochips for Detecting Cancer 51

Manchester University Researchers Develop New Protein Chips

Manufacturing Procedure 51

febit Introduces New Geniom Biochip 52

Agilent Introduces Additions to the HPLC-Chip Line for Proteomics 53

Progenika Develops BLOODchip 53

Roche Introduces Gene Expression Services and Arrays 53

Stratos Biosystems Develops New EC-Affinity Biochips 54

Affymetrix Unveils Affymetrix GeneChip Command Console Software 54

Affymetrix Introduces GeneChip Mouse and Rat Gene 1.0 ST Arrays 55

Affymetrix Unveils Genome-Wide Human SNP Array 6.0 55

Caliper Life Sciences Launches High Throughput RNA Assay 55

Applied Biosystems Unveils DNA Tools 56

febit Launches Geniom RT Analyzer 56

Austrian Research Center Develops New Biochip Surface 57

Researchers Develop Biochips to Eliminate Animal Testing 57

Progenika Biopharma Launches IBD DNA 57

Bioident Develops New Lab-on-a-Chip Nanotiter Plate Prototype 57

Ilochip and University of Denmark Develop a Biochip for Faster

Bird Flu Detection 58

CombiMatrix Develops a Biochip for Leukemia Analysis 58

Affymetrix Launches New Tiling Arrays for Mapping Whole-Genome

Transcript 58

Roche Plans to Launch AmpliChip in Japan 59

Caliper Life Sciences Unveils Desktop Profiler 59

Massachusetts Institute of Technology Develops Portable Lab on

a Chip 59

Optical Device to Develop Lab-on-a-Chip 59

Agilent Launches Five New HPLC Chips 60

Protagen AG Launches New Protein Biochips 60

Fluidigm Releases the 8.96 TOPAZ Screening Chip 60

Affymetrix Releases Chip-on-Chip Array 60

DNA Chip Research Launches High Sensitivity DNA Chip 60

DNA Chip Research and HitachiSoft Unveils AceGene 60

10. RECENT INDUSTRY ACTIVITY 61

Philips and bioMerieux to Produce Biochips for Cardiovascular

Assays 61

Roche Diagnostics and CapitalBio to Sign MOU 61

SVTC Partners with TSMC to Commercialize New Technologies 61

HORIBA Jobin Yvon Takes Over GenOptics 62

GWC Technologies to Receive $100,000 Federal Grant 62

febit to Receive Funds for Biomarker Project 62

Researchers Assess TB-Biochip MDR Test System 63

IBM to Use DNA Chip for Developing Personalized Medicine 63

11. CORPORATE ACTIVITY IN THE RECENT PAST - A PERSPECTIVE BUILDER 64

Invitrogen and Applied Biosystems Merge to Form Life

Technologies Corporation 64

China Medical Technologies Signs Agreement with Molecular

Diagnostics Technologies 64

DNA Chip Acquires HuBit's Gene Analysis Business 64

Affymetrix Acquires USB 65

Roche NimbleGen Forms Alliance with BioDiscovery to Provide

CGH Solutions 65

Illumina Announces Partnership with Genpathway for ChIP

Sequencing Services 65

Jiangsu and IMDi Diagnosis to Establish Joint Venture 66

Plexera Biosciences Enters into an Option Deal with Auguron 66

Affymetrix and Avesthagen Enter into an Agreement 67

Roche NimbleGen and Affymetrix Announce Expansion of License

Agreement 67

Proteomika and Auguron Biosciences Ink Option Agreement 67

Gentel Biosciences and Eppendorf Enter into Global License

Agreement 68

GATC Biotech Establishes New Subsidiary 68

Procognia Spins off Sense Proteomic 69

Johns Hopkins University Purchases MassARRAY System 69

Yale University Purchases MassARRAY System 69

Korea's NIH Extends KARE Project with Affymetrix Technology 69

febit Obtains US Patent for Hybselect, a Microfluidic

Extraction Method 70

Atotech Enters into Research Collaboration with University of

Albany 70

CapitalBio and Beijing National Engineering Research Center

Develop New Biochip Testing System 70

Roche Takes Over NimbleGen 71

GenTel BioSciences Acquires Protein Chip Platform Assets of GSK 71

Advanced Liquid Logic Acquires Nanolytics 72

Applied Microarrays Acquires Select GE Healthcare's Assets 72

Canon, Toshiba and Other Companies to Join Hands for Biochips 73

BioChip Innovations Signs Research Collaboration Agreement

with IME 73

Protagen Enters into a Partnership to Develop Antibodies 73

Spanish Society of Rheumatology Enters into Collaboration with

Progenika 74

Affymetrix and Partners Healthcare Extend Collaboration 74

Agencourt, NuGEN and Affymetrix Clinical Services Collaborate 74

Affymetrix Inks Licensing Agreement with Empire Genomics 75

Caliper Enters into a Licensing Agreement with Monogram

Biosciences 75

Affymetrix and IPSOGEN Sign Agreement 76

bioMérieux and NuGEN Enter into Supply and Cross-License

Agreement 76

VWR and CapitalBio Enter into a Distribution Agreement 77

C3B Bags Contract from Department of Defense to Develop an

Implantable Biochip 77

UCL Subsidiary and Roche Diagnostics Ink Licensing Deal 77

Affymetrix Establishes the European Cytogenetic Research

Initiative 78

Fluidigm Establishes New Development Center 78

Daiichi Pure Chemicals Applies for Approval to Market DNA

Micro-array 78

GE Healthcare Snaps Up Biacore 79

Bio-Rad Acquires Ciphergen's Life Science Research Business 79

Sysmex to Form Partnership with Affymetrix 79

Daiichi, Toshiba Hokuto and Toshiba Join Hands 79

Affymetrix Collaborates with Zhejiang California Nanosystem

Institute 80

Merck Sharp & Dohme and Shanghai Biochip Enter into Co-

operation Agreement 80

Toshiba Signs Licensing Agreement with Antara BioSciences 81

MUSC Signs LOI with Lumera 81

AVIVA Inks Agreement with Japan's Cosmo Bio 81

Lumera Signs Collaborative Agreement with Harvard Medical School 81

Whatman Receives CE Mark for CombiChip 82

IDIBAPS Led Project Receives Approval from European Union 82

Toray to Establish DNA Chip Business 83

Protagen Forays into the US Market 83

Biacore Expands Operations into Chinese Market 83

Nisshinbo to Replace Glass with Resin in DNA Production 83

12. FOCUS ON SELECT GLOBAL PLAYERS 84

Affymetrix Inc (US) 84

Agilent Technologies, Inc. (US) 84

Biomerieux SA (France) 85

Bio-Rad Laboratories, Inc. (US) 85

Caliper Life Sciences, Inc. (US) 85

Cepheid Inc. (US) 86

GE Healthcare Ltd. (UK) 86

Life Technologies Corporation (US) 86

Ocimum Biosolutions Ltd. (India) 87

Takara Bio, Inc. (Japan) 87

Clontech Laboratories, Inc. (US) 88

Zyomyx Inc (US) 88

13. GLOBAL MARKET PERSPECTIVE 89

Table 4: World Recent Past, Current & Future Analysis for

Biochips by Geographic Region - US, Canada, Japan, Europe, and

Rest of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 89

Table 5: World Historic Review for Biochips by Geographic

Region - US, Canada, Japan, Europe, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 90

Table 6: World 11-Year Perspective for Biochips by Geographic

Region - Percentage Breakdown of Dollar Sales for US, Canada,

Japan, Europe, and Rest of World Markets for Years 2005, 2010&

2015 (includes corresponding Graph/Chart) 91

Table 7: World Recent Past, Current & Future Analysis for DNA

Chips by Geographic Region - US, Canada, Japan, Europe, and

Rest of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 92

Table 8: World Historic Review for DNA Chips by Geographic

Region - US, Canada, Japan, Europe, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 93

Table 9: World 11-Year Perspective for DNA Chips by Geographic

Region - Percentage Breakdown of Dollar Sales for US, Canada,

Japan, Europe, and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 94

Table 10: World Recent Past, Current & Future Analysis for

Protein Chips by Geographic Region - US, Canada, Japan,

Europe, and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 95

Table 11: World Historic Review for Protein Chips by

Geographic Region - US, Canada, Japan, Europe, and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 96

Table 12: World 11-Year Perspective for Protein Chips by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, and Rest of World Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 97

Table 13: World Recent Past, Current & Future Analysis for Lab

Chips by Geographic Region - US, Canada, Japan, Europe, and

Rest of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 98

Table 14: World Historic Review for Lab Chips by Geographic

Region - US, Canada, Japan, Europe, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 99

Table 15: World 11-Year Perspective for Lab Chips by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, and Rest of World Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 100

14. THE UNITED STATES 101

A.Market Analysis 101

Outlook 101

An Insight into Biochip Products & Services Market 101

Rapid Growth for Protein, Lab Biochips 101

Robust Demand for Biochip Reagents and Consumables 102

Growth Prospects for Biochip Instruments & Software 102

Potential for Biochip Service Revenues 103

Biochip Product & Service Demand Among Biotech Companies 103

Biochip Products and Services Demand in Life Science

Research Applications 103

Laboratory Chips Market 104

Table 16: US Laboratory Chip Market by Application (2007 &

2015P): Percentage Share Breakdown of Revenues for Life

Science Research, Forensic Medicine, In Vitro Diagnostic

Testing, Drugs-of- Abuse Testing, Disease Management, and

Others (includes corresponding Graph/Chart) 104

Competitive Landscape 105

Table 17: Leading Players in the US Biochip Products and

Services Market (2007): Percentage Share Breakdown of

Revenues for Illumina, Affymetrix, Applied Biosystems,

GE/Amersham, Invitrogen, Bio-Rad, Caliper Life Science,

Cepheid, Agilent Techs, Beckman Coulter, and Others

(includes corresponding Graph/Chart) 105

B.Market Analytics 106

Table 18: US Recent Past, Current & Future Analysis for

Biochips by Product Segment - DNA Chips, Protein Chips and

Lab Chips Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 106

Table 19: US Historic Review for Biochips by Product Segment-

DNA Chips, Protein Chips and Lab Chips Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 106

Table 20: US 11-Year Perspective for Biochips by Product

Segment - Percentage Breakdown of Dollar Sales for DNA

Chips, Protein Chips and Lab Chips Markets for Years 2005,

2010 & 2015 (includes corresponding Graph/Chart) 107

15. CANADA 108

Market Analysis 108

Table 21: Canadian Recent Past, Current & Future Analysis

for Biochips by Product Segment - DNA Chips, Protein Chips

and Lab Chips Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 108

Table 22: Canadian Historic Review for Biochips by Product

Segment - DNA Chips, Protein Chips and Lab Chips Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 109

Table 23: Canadian 11-Year Perspective for Biochips by

Product Segment - Percentage Breakdown of Dollar Sales for

DNA Chips, Protein Chips and Lab Chips Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 109

16. JAPAN 110

A.Market Analysis 110

Outlook 110

ICAN ™ Technology for Large-Scale Production of DNA Fragments 110

B.Market Analytics 111

Table 24: Japanese Recent Past, Current & Future Analysis

for Biochips by Product Segment - DNA Chips, Protein Chips

and Lab Chips Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 111

Table 25: Japanese Historic Review for Biochips by Product

Segment - DNA Chips, Protein Chips and Lab Chips Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 112

Table 26: Japanese 11-Year Perspective for Biochips by

Product Segment - Percentage Breakdown of Dollar Sales for

DNA Chips, Protein Chips and Lab Chips Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 113

17. EUROPE 114

A.Market Analysis 114

Outlook 114

Lab-on-chip Market in Europe 114

European Advancements Shape Diagnostic Procedures 115

B.Market Analytics 116

Table 27: European Recent Past, Current & Future Analysis

for Biochips by Geographic Region - France, Germany, UK, and

Rest of Europe Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 116

Table 28: European Historic Review for Biochips by

Geographic Region - France, Germany, UK, and Rest of Europe

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 117

Table 29: European 11-Year Perspective for Biochips by

Geographic Region - Percentage Breakdown of Dollar Sales for

France, Germany, UK, and Rest of Europe Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 118

Table 30: European Recent Past, Current & Future Analysis

for Biochips by Product Segment - DNA Chips, Protein Chips

and Lab Chips Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 119

Table 31: European Historic Review for Biochips by Product

Segment - DNA Chips, Protein Chips and Lab Chips Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 120

Table 32: European 11-Year Perspective for Biochips by

Product Segment - Percentage Breakdown of Dollar Sales for

DNA Chips, Protein Chips and Lab Chips Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 121

17a. FRANCE 122

Market Analysis 122

Table 33: French Recent Past, Current & Future Analysis for

Biochips by Product Segment - DNA Chips, Protein Chips and

Lab Chips Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 122

Table 34: French Historic Review for Biochips by Product

Segment - DNA Chips, Protein Chips and Lab Chips Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 123

Table 35: French 11-Year Perspective for Biochips by Product

Segment - Percentage Breakdown of Dollar Sales for DNA

Chips, Protein Chips and Lab Chips Markets for Years 2005,

2010 & 2015 (includes corresponding Graph/Chart) 124

17b. GERMANY 125

A.Market Analysis 125

Outlook 125

Berlin, Brandenburg and Biochips 125

B.Market Analytics 126

Table 36: German Recent Past, Current & Future Analysis for

Biochips by Product Segment - DNA Chips, Protein Chips and

Lab Chips Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 126

Table 37: German Historic Review for Biochips by Product

Segment - DNA Chips, Protein Chips and Lab Chips Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 127

Table 38: German 11-Year Perspective for Biochips by Product

Segment - Percentage Breakdown of Dollar Sales for DNA

Chips, Protein Chips and Lab Chips Markets for Years 2005,

2010 & 2015 (includes corresponding Graph/Chart) 128

17c. THE UNITED KINGDOM 129

Market Analysis 129

Table 39: UK Recent Past, Current & Future Analysis for

Biochips by Product Segments- DNA Chips, Protein Chips and

Lab Chips Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 129

Table 40: UK Historic Review for Biochips by Product Segment-

DNA Chips, Protein Chips and Lab Chips Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 130

Table 41: UK 11-Year Perspective for Biochips by Product

Segment - Percentage Breakdown of Dollar Sales for DNA

Chips, Protein Chips and Lab Chips Markets for Years 2005,

2010 & 2015 (includes corresponding Graph/Chart) 131

17d. REST OF EUROPE 132

Market Analysis 132

Table 42: Rest of Europe Recent Past, Current & Future

Analysis for Biochips by Product Segment - DNA Chips,

Protein Chips and Lab Chips Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2007

through 2015 (includes corresponding Graph/Chart) 132

Table 43: Rest of Europe Historic Review for Biochips by

Product Segment - DNA Chips, Protein Chips and Lab Chips

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 133

Table 44: Rest of Europe11-Year Perspective for Biochips by

Product Segment - Percentage Breakdown of Dollar Sales for

DNA Chips, Protein Chips and Lab Chips Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 134

18. REST OF WORLD 135

A.Market Analysis 135

Outlook 135

China 135

Basic Environment and Commercial Development 135

Biochip Research Institutes 136

Taiwan 136

Taiwan Pursues Promise of Biochip Sector 136

International Advantage Sought 137

B.Market Analytics 138

Table 45: Rest of World Recent Past, Current & Future

Analysis for Biochips by Product Segment - DNA Chips,

Protein Chips and Lab Chips Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2007

through 2015 (includes corresponding Graph/Chart) 138

Table 46: Rest of World Historic Review for Biochips by

Product Segment - DNA Chips, Protein Chips and Lab Chips

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 139

Table 47: Rest of World 11-Year Perspective for Biochips by

Product Segment - Percentage Breakdown of Dollar Sales for

DNA Chips, Protein Chips and Lab Chips Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 140

COMPETITIVE LANDSCAPE

Total Companies Profiled: 77 (including Divisions/Subsidiaries - 87)

------------------------------------------

Region/Country Players

------------------------------------------

The United States 40

Japan 14

Europe 24

France 4

Germany 8

The United Kingdom 4

Spain 1

Rest of Europe 7

Asia-Pacific (Excluding Japan) 9

------------------------------------------

To order this report:

: Global Biochips Industry

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

CONTACT:
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related biology technology :

1. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
2. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
3. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
4. Reportlinker Adds Proteomics: Technologies and Global Markets Report
5. Reportlinker Adds Nanomedicine Report
6. Reportlinker Adds Small Molecule Kinase Inhibitors Report
7. Reportlinker Adds Nanoporous Materials Report
8. Reportlinker Adds Membrane Bioreactors Report
9. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
10. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
11. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report ... detail how a patient who developed lymphedema after being treated for breast cancer benefitted ... change the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... quality, regulatory and technical consulting, provides a free webinar on Performing ... July 13, 2016 at 12pm CT at no charge. , Incomplete investigations are ...
(Date:6/23/2016)... ReportsnReports.com adds 2016 global ... pharmaceuticals section with historic and forecast data along ... Complete report on the Cell Culture ... companies and supported with 261 tables and figures ... The Global Cell Culture Media Industry ...
Breaking Biology Technology:
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
Breaking Biology News(10 mins):